Onconetix, Inc. Preferred Stock Dividends and Other Adjustments
Onconetix, Inc. (ONCO) reported Preferred Stock Dividends and Other Adjustments of $96.36 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2023-10-20
- Onconetix, Inc. preferred stock dividends and other adjustments for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Onconetix, Inc. preferred stock dividends and other adjustments for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Onconetix, Inc. preferred stock dividends and other adjustments for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Onconetix, Inc. preferred stock dividends and other adjustments for the quarter ending 2022-03-31 was $96.36K, a 30.02% decline year-over-year.
- Onconetix, Inc. preferred stock dividends and other adjustments for fiscal 2022 was $96.36K, a 84.64% decline from fiscal 2021.
- Onconetix, Inc. preferred stock dividends and other adjustments for fiscal 2021 was $627.39K.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-09 | $0.00 derived: sum of 3 quarters · filed 2023-10-20 | $96.36K 10-K · filed 2023-03-09 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-10-20 | $96.36K 10-Q · filed 2022-11-14 | $260.53K derived: sum of 4 quarters · filed 2023-10-20 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-20 | $96.36K 10-Q · filed 2023-10-20 | $260.53K derived: sum of 3 quarters · filed 2023-10-20 | $446.85K derived: sum of 4 quarters · filed 2023-10-20 |
| 2022-03-31 | $96.36K 10-Q · filed 2023-05-12 | $260.53K derived: sum of 2 quarters · filed 2023-05-12 | $446.85K derived: sum of 3 quarters · filed 2023-05-12 | $586.06K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $164.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $350.49K derived: sum of 2 quarters · filed 2023-03-09 | $489.70K derived: sum of 3 quarters · filed 2023-03-09 | $627.39K 10-K · filed 2023-03-09 |
| 2021-09-30 | $186.32K 10-Q · filed 2022-11-14 | $325.54K derived: sum of 2 quarters · filed 2022-11-14 | $463.22K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $139.22K 10-Q · filed 2022-08-15 | $276.90K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $137.69K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |